In secondary analysis of the subsample that only included patients with DM, neither the type of treatment (insulin vs. oral medications) nor length of treatment (none, < 2 years, or ≥ 2 years) was associated with adenomatous polyps (Table 4). This evidence concerns the gene INS and diabetes mellitus.